Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.
Saved in:
| Title: | Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group. |
|---|---|
| Authors: | Frangoul H; Children's Hospital & Regional Medical Center, Seattle, Washington, USA., Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 1999 Dec; Vol. 5 (12), pp. 3956-62. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
